Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody

Este producto es parte de HEXA - Beta-Hexosaminidase Subunit Alpha
Product Graph
357.5€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx146346
tested applications
ELISA, WB, IHC

Description

HEXA Antibody is a Rabbit Polyclonal against HEXA.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Beta-Hexosaminidase Subunit Alpha (HEXA)
Host
Rabbit
Reactivity
Human
Recommended Dilution
ELISA: 1/20000 - 1/80000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purification
Purified by antigen affinity column chromatography.
Size 1
100 µg
Size 2
1 mg
Form
Lyophilized
Tested Applications
ELISA, WB, IHC
Buffer
Prior to lyophilization: 1% BSA and 0.02% NaN3.
Availability
Shipped within 7-15 working days.
Storage
Store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
NCBI Accession
BC018927
Alias
N-acetyl-beta-glucosaminidase subunit alpha,TSD
Background
Antibody anti-HEXA
Status
RUO
Note
Concentration: Lyophilized form: Not applicable.  After reconstitution: 1 mg/ml. -

Descripción

HEXA is the alpha subunit of the beta-hexosaminidase enzyme, a lysosomal hydrolase that catalyzes the breakdown of GM2 gangliosides into GM3 in the process of glycosphingolipid degradation The enzyme functions as a heterodimer composed of alpha and beta subunits, encoded by the HEXA and HEXB genes respectively Mutations in HEXA lead to Tay-Sachs disease, an autosomal recessive lysosomal storage disorder characterized by the accumulation of GM2 gangliosides in neuronal cells, resulting in neurodegeneration, progressive motor weakness, and developmental delay HEXA is highly active in neuronal tissues where glycosphingolipid metabolism is critical for normal brain function The absence or dysfunction of HEXA causes a loss of enzymatic activity leading to cellular toxicity and apoptosis Current therapeutic approaches include enzyme replacement therapy, substrate reduction therapy, and gene therapy to restore HEXA activity and slow disease progression

Related Products

abx137331

Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody

Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody is a Mouse Monoclonal antibody against Beta-Hexosaminidase Subunit Alpha (HEXA).

Ver Producto
abx233843

Beta-Hexosaminidase Subunit Alpha (HEXA) Antibody

HEXA Antibody is a Mouse Monoclonal against HEXA.

Ver Producto
abx691409

Human Beta-Hexosaminidase Subunit Alpha (HEXA) Protein (Active)

Human Hexosaminidase A Protein is a recombinant protein from Human produced in Baculovirus-Insect Cells. A DNA sequence encoding the human HEXA (AAD13932.1) (Met 1-Thr 529) was fused with a polyhistidine tag at the C-terminus.

Ver Producto